Improved prognosis by trastuzumab of women with HER2-positive breast cancer compared with those with HER2-negative disease
- PMID: 20479395
- DOI: 10.1200/JCO.2010.28.2525
Improved prognosis by trastuzumab of women with HER2-positive breast cancer compared with those with HER2-negative disease
Comment on
-
Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review.J Clin Oncol. 2010 Jan 1;28(1):92-8. doi: 10.1200/JCO.2008.19.9844. Epub 2009 Nov 23. J Clin Oncol. 2010. PMID: 19933921 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
